US Stocks Down; Jobless Claims Rise To 231,000
Portfolio Pulse from Lisa Levin
U.S. stocks traded lower with the Dow, NASDAQ, and S&P 500 all seeing declines after jobless claims data showed an increase to 231,000, the highest in three months. Utilities shares surged, while energy shares fell. Apollomics, WaveDancer, and Bone Biologics saw significant stock price increases, whereas Volcon, Nogin, and Velo3D experienced substantial drops. Oil prices decreased, while gold and silver prices increased.
November 16, 2023 | 2:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apollomics' stock surged 83% after approval of vebreltinib for a type of lung cancer.
The approval of vebreltinib is a significant positive development for Apollomics, likely to boost investor confidence and drive short-term stock performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Bone Biologics Corporation shares increased by 67%, but no specific news was identified in the article to justify the rise.
The article does not provide a clear reason for the stock's rise, making it difficult to assess the sustainability of the increase.
CONFIDENCE 50
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
WaveDancer's shares jumped 74% following a definitive merger agreement with Firefly Neuroscience.
The merger announcement with Firefly Neuroscience is a major catalyst for WaveDancer's stock, indicating potential growth and expansion.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Nogin, Inc. shares fell 34%, but the article does not provide a specific reason for the decline.
Without clear information on the cause of the decline, it's challenging to predict the stock's short-term trajectory.
CONFIDENCE 50
IMPORTANCE 50
RELEVANCE 50
NEGATIVE IMPACT
Volcon's shares plummeted 62% after announcing an $18 million underwritten public offering.
The public offering is likely dilutive to existing shareholders, causing a negative reaction in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Velo3D's stock decreased by 24%, with no specific catalyst mentioned in the article.
The article does not explain the reason for Velo3D's stock decline, making it difficult to assess the impact.
CONFIDENCE 50
IMPORTANCE 50
RELEVANCE 50